Literature DB >> 20083909

Regulation of inflammation by the protein C system.

Hartmut Weiler1.   

Abstract

OBJECTIVE: To review new findings about the function of the protein C system during inflammation and coagulation. MAIN
FINDINGS: Coagulation proteases and their cofactors modify the outcome of severe inflammation by engaging signaling-competent cell surface receptors. The central effector protease of the protein C pathway, activated protein C, interacts with the endothelial cell protein C receptor, protease-activated receptors, and other receptors to exert multiple effects on hemostasis and immune cell function. Thrombomodulin controls the complement arm of the innate immune system in a thrombin-dependent manner through activation of the thrombin activatable inhibitor of fibrinolysis, and in a thrombin-independent, constitutive manner via its lectin-like extracellular domain; and inhibits the inflammatory effects of high-mobility box group 1 protein. Protein S not only suppresses coagulation as an enhancing cofactor for the coagulation inhibitors activated protein C and tissue factor pathway inhibitor but also is also a physiologic ligand for the Tyro/axl/Mer-family of receptor tyrosine kinases that mediate an anti-inflammatory regulatory loop of dendritic cell and monocyte inflammatory function.
CONCLUSIONS: The immune-regulatory capacity of the protein C pathway and its individual components emerge as the dominant action of this pathway in the setting of severe inflammation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20083909     DOI: 10.1097/CCM.0b013e3181c9cbb5

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  20 in total

1.  To survive radiation injury, remember your aPCs.

Authors:  John P Chute
Journal:  Nat Med       Date:  2012-07-06       Impact factor: 53.440

2.  Inhibition of endogenous activated protein C attenuates experimental autoimmune encephalomyelitis by inducing myeloid-derived suppressor cells.

Authors:  Leah M Alabanza; Naomi L Esmon; Charles T Esmon; Margaret S Bynoe
Journal:  J Immunol       Date:  2013-08-30       Impact factor: 5.422

Review 3.  Mechanisms of anticoagulant and cytoprotective actions of the protein C pathway.

Authors:  E A M Bouwens; F Stavenuiter; L O Mosnier
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

4.  Polyphosphate suppresses complement via the terminal pathway.

Authors:  Jovian M Wat; Jonathan H Foley; Michael J Krisinger; Linnette Mae Ocariza; Victor Lei; Gregory A Wasney; Emilie Lameignere; Natalie C Strynadka; Stephanie A Smith; James H Morrissey; Edward M Conway
Journal:  Blood       Date:  2013-12-13       Impact factor: 22.113

5.  Human platelets express endothelial protein C receptor, which can be utilized to enhance localization of factor VIIa activity.

Authors:  A M Fager; K R Machlus; M Ezban; M Hoffman
Journal:  J Thromb Haemost       Date:  2018-06-27       Impact factor: 5.824

6.  Protein C concentrate controls leukocyte recruitment during inflammation and improves survival during endotoxemia after efficient in vivo activation.

Authors:  David Frommhold; Julia Tschada; Natascha Braach; Kirsten Buschmann; Axel Doerner; Johanna Pflaum; Marie-Sophie Stahl; Hongjie Wang; Lutz Koch; Markus Sperandio; Angelika Bierhaus; Berend Isermann; Johannes Poeschl
Journal:  Am J Pathol       Date:  2011-09-09       Impact factor: 4.307

Review 7.  Interface between hemostasis and adaptive immunity.

Authors:  Zheng Qu; Elliot L Chaikof
Journal:  Curr Opin Immunol       Date:  2010-10-11       Impact factor: 7.486

8.  Plasma bacterial and mitochondrial DNA distinguish bacterial sepsis from sterile systemic inflammatory response syndrome and quantify inflammatory tissue injury in nonhuman primates.

Authors:  Tolga Sursal; Deborah J Stearns-Kurosawa; Kiyoshi Itagaki; Sun-Young Oh; Shiqin Sun; Shinichiro Kurosawa; Carl J Hauser
Journal:  Shock       Date:  2013-01       Impact factor: 3.454

9.  Pharmacological targeting of the thrombomodulin-activated protein C pathway mitigates radiation toxicity.

Authors:  Hartmut Geiger; Snehalata A Pawar; Edward J Kerschen; Kalpana J Nattamai; Irene Hernandez; Hai Po H Liang; Jose Á Fernández; Jose A Cancelas; Marnie A Ryan; Olga Kustikova; Axel Schambach; Qiang Fu; Junru Wang; Louis M Fink; Karl-Uwe Petersen; Daohong Zhou; John H Griffin; Christopher Baum; Hartmut Weiler; Martin Hauer-Jensen
Journal:  Nat Med       Date:  2012-07       Impact factor: 53.440

Review 10.  Shiga toxins and the pathophysiology of hemolytic uremic syndrome in humans and animals.

Authors:  Chad L Mayer; Caitlin S Leibowitz; Shinichiro Kurosawa; Deborah J Stearns-Kurosawa
Journal:  Toxins (Basel)       Date:  2012-11-08       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.